ClinicalTrials.gg
Sign In

Median Neuropathy clinical trials

The registry lists 74 studies for Median Neuropathy across more than 10 countries. 19 are recruiting or about to start. 20 of them are mainly about Median Neuropathy (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-04. Counting its narrower condition Carpal Tunnel Syndrome too: 613 studies, 140 open.

Get an email when these change. Save the Median Neuropathy studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
41
Recruiting
12
Status unknown
9
Not yet recruiting
7
Terminated
2
Withdrawn
2

Phase

Phase 4
3
Phase 3
1
Phase 2
1
Phase 1
1

Where

Turkey
21
United States
15
Egypt
5
Canada
4
Brazil
4
Spain
3

Who runs them

Afyonkarahisar Health Sciences University (4) · Istanbul University (4) · Mayo Clinic (3) · Hospital Italiano de Buenos Aires (2) · Istanbul University - Cerrahpasa (2) · Cairo University (2) · Elsan (1) · Beylikduzu State Hospital (1)

What is being tested here

Drugs under test in Median Neuropathy studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Dexmedetomidine102
Cannabidiol101
Ozone101
Dexamethasone101
Acetylcysteine101
Bupivacaine001
Acetaminophen001
Ibuprofen001
Hydrocodone001
Fospropofol011

Coming up

0phase 3 studies under way
3studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

All 3

Who these studies take

Of the 12 Median Neuropathy studies recruiting now, 4 (33%) set no upper age limit and 7 (58%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 2 (17%) take healthy volunteers.

Recruiting studies that take each age, of 12
AgeWomenMen
100 (0%)0 (0%)
1810 (83%)10 (83%)
3012 (100%)12 (100%)
4012 (100%)12 (100%)
5012 (100%)12 (100%)
6511 (92%)11 (92%)
756 (50%)6 (50%)
854 (33%)4 (33%)

Across all 74 studies, recruiting or not: 49% stop at 75 or younger and 39% at 65; 3% take children; 5% are for women only and 3% for men only; 22% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Median Neuropathy studies take

Of 42 interventional studies with no phase under Median Neuropathy, half reached primary completion within 14 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase14 mo7–26 · 42 studies—14 mo6–26 · 38 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting1

Results posted1

Studies

Recruiting first, then most recently updated. Showing 50 of 74. Browse all 74 → or search them.